BVT Discount Zert TEVA 27.09.2024/ DE000VM79UU6 /
17.06.2024 10:34:34 | Изменение-0.010 | Бид11:16:21 | Предложение11:16:21 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
11.830EUR | -0.08% | 11.830 Величина цены спроса: 4,000 |
12.080 Величина цены предложения: 4,000 |
Teva Pharmaceutical ... | - USD | 27.09.2024 | Call |
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market
GlobeNewswire
10:00
Castle Ridge announces launch of Multi-Strategy powered by WALLACE AI supercomputer
GlobeNewswire
10:00
Cognitiv Partners With Adform to Offer ContextGPT™ to European Advertisers for the First Time
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
9:01
AMERICAN SALARS ACQUIRES POCITOS LITHIUM SALAR PROJECT WITH INFERRED LITHIUM CARBONATE MINERAL RESOU...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница